Evidence map›Paper›PMID 28219889›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2017

Rapid and Rigorous IL-17A Production by a Distinct Subpopulation of Effector Memory T Lymphocytes Constitutes a Novel Mechanism of Toxic Shock Syndrome Immunopathology.

Peter A Szabo, Ankur Goswami, Delfina M Mazzuca, Kyoungok Kim, David B O'Gorman, David A Hess, Ian D Welch, Howard A Young, Bhagirath Singh, John K McCormick and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Superantigens promoteProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  11. Roles of the gut microbiota in severe SARS-CoV-2 infection.Cytokine & growth factor reviews · 2022
    Review
  12. Observational
  13. Humanized Mice as a Tool to Study Sepsis-More Than Meets the Eye.International journal of molecular sciences · 2021
    Review
  14. Article
  15. Article
  16. Review
  17. Immune Response in Bacterial andEuropean journal of microbiology & immunology · 2019
    Review
  18. Article
  19. Immunity toMicrobiology spectrum · 2019
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Peter A SzaboDepartment of Microbiology and Immunology, Western University, London, Ontario N6A 5C1, Canada.
Ankur GoswamiDepartment of Microbiology and Immunology, Western University, London, Ontario N6A 5C1, Canada.
Delfina M MazzucaDepartment of Microbiology and Immunology, Western University, London, Ontario N6A 5C1, Canada.
Kyoungok KimDepartment of Microbiology and Immunology, Western University, London, Ontario N6A 5C1, Canada.
David B O'GormanCell and Molecular Biology Laboratory, Roth | McFarlane Hand and Upper Limb Centre, Western University, London, Ontario N6A 4V2, Canada.ORCID 0000-0001-6195-2644
David A HessDepartment of Physiology and Pharmacology, Western University, London, Ontario N6A 5C1, Canada.
Ian D WelchDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada.
Howard A YoungCancer and Inflammation Program, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD 21702.ORCID 0000-0002-3118-5111
Bhagirath SinghDepartment of Microbiology and Immunology, Western University, London, Ontario N6A 5C1, Canada.ORCID 0000-0002-9792-8694
John K McCormickDepartment of Microbiology and Immunology, Western University, London, Ontario N6A 5C1, Canada.ORCID 0000-0003-3742-7289
S M Mansour HaeryfarDepartment of Microbiology and Immunology, Western University, London, Ontario N6A 5C1, Canada; Mansour.Haeryfar@schulich.uwo.ca.ORCID 0000-0002-1125-8176
Western University · CAFrederick National Laboratory for Cancer Research · USUniversity of British Columbia · CA

Funding

CIHR MOP-130465Intramural NIH HHS Z99 CA999999
6 · The paper itself

Abstract

Toxic shock syndrome (TSS) is caused by staphylococcal and streptococcal superantigens (SAgs) that provoke a swift hyperinflammatory response typified by a cytokine storm. The precipitous decline in the host's clinical status and the lack of targeted therapies for TSS emphasize the need to identify key players of the storm's initial wave. Using a humanized mouse model of TSS and human cells, we herein demonstrate that SAgs elicit in vitro and in vivo IL-17A responses within hours. SAg-triggered human IL-17A production was characterized by remarkably high mRNA stability for this cytokine. A distinct subpopulation of CD4

Indexed as

AnimalsDisease Models, AnimalFlow CytometryGram-Positive Bacterial InfectionsHumansImmunologic MemoryInterleukin-17MiceMice, Inbred C57BLPolymerase Chain ReactionShock, SepticT-LymphocytesT-Lymphocyte SubsetsInterleukin-17

Identifiers

PMID28219889
PMCPMC6635948
OpenAlexW2599208050

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.